Related by context. Frequent words. (Click for all words.) 70 refractory chronic lymphocytic 68 leukemia ALL 67 relapsing multiple sclerosis 67 systemic lupus erythematosus SLE 67 forodesine 66 leukemia CLL 66 Chronic Lymphocytic Leukemia 66 Amrubicin 66 multiple myeloma MM 66 hepatocellular carcinoma HCC 66 systemic lupus erythematosus 66 malignant pleural mesothelioma 66 chronic lymphocytic leukemia CLL 65 myelodysplastic syndrome MDS 65 lupus nephritis 65 cell acute lymphoblastic 65 R sorafenib tablets 65 Epratuzumab 65 Chronic Heart Failure 65 myeloproliferative disorders 65 HER2 positive metastatic breast 65 Natalizumab 65 Alemtuzumab 64 superficial bladder cancer 64 Acute Myeloid Leukemia AML 64 metastatic hormone refractory 64 acute myelogenous leukemia AML 64 non squamous NSCLC 64 Diabetic Macular Edema 64 bone metastasis 64 mRCC 64 heavily pretreated 64 relapsed refractory multiple myeloma 64 non Hodgkin lymphomas 64 medullary thyroid cancer 64 lymphoma CTCL 64 carcinoid tumors 64 metastatic castration resistant 64 Voreloxin 64 SHPT 63 indolent NHL 63 recurrent ovarian cancer 63 colorectal carcinoma 63 ixabepilone 63 Lenalidomide 63 metastatic renal cell carcinoma 63 IV melanoma 63 relapsed refractory 63 Ischemic 63 recurrent glioblastoma 63 registrational trial 63 Presents Positive 63 TREANDA 63 Idiopathic Pulmonary Fibrosis 63 secondary hyperparathyroidism 63 axitinib 63 Panzem R 63 Daclizumab 63 anticancer compound 63 pancreatic neuroendocrine tumors 63 SAR# [004] 63 liposomal formulation 63 luteinizing hormone releasing 63 hepatitis C HCV 62 multi kinase inhibitor 62 enzastaurin 62 Clinical Trial Results 62 colorectal cancer CRC 62 resistant ovarian cancer 62 Etanercept 62 paroxysmal nocturnal hemoglobinuria PNH 62 Laquinimod 62 Vandetanib 62 Pivotal Phase III 62 proteasome inhibitor 62 investigational compounds 62 pertuzumab 62 gastrointestinal stromal tumors 62 phase IIb clinical 62 Irinotecan 62 INCB# [001] 62 Gemzar ® 62 myelodysplasia 62 metastatic lung cancer 62 KRN# 62 Metastatic Melanoma 62 Metastatic Colorectal Cancer 62 hepatocellular cancer 62 Factor VIIa 62 elotuzumab 62 bendamustine 62 Dapagliflozin 62 angiogenesis inhibitor 62 Pivotal Trial 62 pancreatic NET 62 bosutinib 62 chronic myelogenous leukemia CML 62 Chronic Hepatitis C 62 Gynecologic Oncology Group 62 Cetrorelix 62 relapsing remitting multiple sclerosis